Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples